EGFR and carcinoma: In conclusion, CD27xEGFR is a novel DVD-Ig bsAb targeting CD27 and EGFR, that has the potential to re-activate T cell immunity in EGFR+ carcinomas through its interaction with tumor-reactive and exhausted CD27+CD8+ TILs.